MedTrace Logo

Investigating Mild Cognitive Impairment in Patients And Controls With TD-fNIRS

NCT05996575 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 133

Last updated 2024-07-03

No results posted yet for this study

Summary

The goal of the proposed observational, multi-site study is to use fNIRS neurophysiological data recorded during a battery of tasks to detect MCI within a cohort consisting of patients and age-matched healthy controls. Furthermore, the investigators aim to explore whether they can measure the severity of MCI symptoms in the patient population. If successful, this approach enables clinicians to track the disease at its source-the brain; possibly allowing for earlier detection of MCI and its progression, and ultimately more efficient interventions.

Conditions

Interventions

OTHER

fNIRS measurement

Kernel Flow2 measurements.

Sponsors & Collaborators

  • Kernel

    lead INDUSTRY

Principal Investigators

  • Katherine Perdue, PhD · Kernel

Eligibility

Min Age
55 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-25
Primary Completion
2024-06-13
Completion
2024-06-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05996575 on ClinicalTrials.gov